Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: Novel insights into molecular targets and interventions using prebiotics

Beneficial Microbes

Volumn 5, Issue 1, 2014, Pages 3-17

  Geurts, L ^a,b   Neyrinck, A M ^b   Delzenne, N M ^b   Knauf, C ^c,d   Cani, P D ^a,b  

^a Welbio   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c INSERM   (France)

^d University Hospital of Toulouse   (France)

Author keywords

Apelin; Endocannabinoid system; Metabolic endotoxaemia; Obesity; Type 2 diabetes

Indexed keywords

APELIN; APELIN RECEPTOR; ARABINOXYLAN; CHITIN; ENDOCANNABINOID; FRUCTAN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; PEPTIDE YY; POLYPHENOL; POMEGRANATE EXTRACT; PREBIOTIC AGENT;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ASPERGILLUS NIGER; BACTEROIDETES; BIFIDOBACTERIUM; CLOSTRIDIUM; DISEASE ASSOCIATION; ENERGY BALANCE; ENTEROENDOCRINE CELL; FAECALIBACTERIUM PRAUSNITZII; FATTY LIVER; FIRMICUTES; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; IMMUNITY; INSULIN RESISTANCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; LIPOPOLYSACCHARIDE-INDUCED ENDOTOXEMIA; METABOLIC DISORDER; METABOLIC REGULATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW;

APELIN; ENDOCANNABINOID SYSTEM; METABOLIC ENDOTOXAEMIA; OBESITY; TYPE 2 DIABETES;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, TYPE 2; ENDOCANNABINOIDS; ENDOTOXEMIA; FATTY LIVER; GASTROINTESTINAL TRACT; GLUCOSE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPOPOLYSACCHARIDES; LIVER; MICE; MICROBIOTA; OBESITY; PREBIOTICS;

EID: 84894331103     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2012.0065     Document Type: Review

References (122)

1. Alhamoruni, A., Wright, K.L., Larvin, M. and O'Sullivan, S.E., 2012. Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. British Journal of Pharmacology 165: 2598--2610.
2. Angelakis, E., Armougom, F., Million, M. and Raoult, D., 2012. The relationship between gut microbiota and weight gain in humans. Future Microbiology 7: 91-109.
3. Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F. and Gordon, J.I., 2004. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the USA 101: 15718-15723.
4. Backhed, F., Manchester, J.K., Semenkovich, C.F. and Gordon, J.I., 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the USA 104: 979-984.
5. Basu, A. and Penugonda, K., 2009. Pomegranate juice: a heart-healthy fruit juice. Nutrition Reviews 67: 49-56.
6. Bays, H.E., Evans, J.L., Maki, K.C., Evans, M., Maquet, V., Cooper, R. and Anderson, J.W., 2013. Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial. European Journal of Clinical Nutrition 67: 2-7.
7. Bensaid, M., Gary-Bobo, M., Esclangon, A., Maffrand, J.P., Le, F.G., Oury-Donat, F. and Soubrie, P., 2003. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Molecular Pharmacology 63: 908-914.
8. Bialonska, D., Ramnani, P., Kasimsetty, S.G., Muntha, K.R., Gibson, G.R. and Ferreira, D., 2010. The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. International Journal of Food Microbiology 140: 175--182.
9. Bird, A.R., Conlon, M.A., Christophersen, C.T. and Topping, D.L., 2010. Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Beneficial Microbes 1: 423-431.
10. Bluher, M., Engeli, S., Kloting, N., Berndt, J., Fasshauer, M., Batkai, S., Pacher, P., Schon, M.R., Jordan, J. and Stumvoll, M., 2006. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55: 3053-3060.
11. Boesten, R.J. and De Vos, W.M., 2008. Interactomics in the human intestine: lactobacilli and bifidobacteria make a difference. Journal of Clinical Gastroenterology 42 Suppl. 3 Part 2: S163-S167.
12. Boesten, R.J., Schuren, F.H. and De Vos, W.M., 2009. A Bifidobacterium mixed-species microarray for high resolution discrimination between intestinal bifidobacteria. Journal of Microbiological Methods 76: 269-277.
13. Broekaert, W.F., Courtin, C.M., Verbeke, K., Van de Wiele, T., Verstraete, W. and Delcour, J.A., 2011. Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Critical Reviews in Food Science and Nutrition 51: 178-194.
14. Brun, P., Castagliuolo, I., Leo, V.D., Buda, A., Pinzani, M., Palu, G. and Martines, D., 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. American Journal of Physiology - Gastrointestinal and Liver Physiology 292: G518-G525.
15. Cani, P.D. and Delzenne, N.M., 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Current Pharmaceutical Design 15: 1546-1558.
16. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J.F., Gibson, G.R., Casteilla, L., Delzenne, N.M., Alessi, M.C. and Burcelin, R., 2007a. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
17. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
18. Cani, P.D., Daubioul, C.A., Reusens, B., Remacle, C., Catillon, G. and Delzenne, N.M., 2005a. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. Journal of Endocrinology 185: 457--465.
19. Cani, P.D., Joly, E., Horsmans, Y. and Delzenne, N.M., 2006a. Oligofructose promotes satiety in healthy human: a pilot study. European Journal of Clinical Nutrition 60: 567-572.
20. Cani, P.D., Knauf, C., Iglesias, M.A., Drucker, D.J., Delzenne, N.M. and Burcelin, R., 2006b. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55: 1484-1490.
21. Cani, P.D., Lecourt, E., Dewulf, E.M., Sohet, F.M., Pachikian, B.D., Naslain, D., De, B.F., Neyrinck, A.M. and Delzenne, N.M., 2009a. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. The American Journal of Clinical Nutrition 90: 1236-1243.
22. Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., Gibson, G.R. and Delzenne, N.M., 2007b. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383.
23. Cani, P.D., Neyrinck, A.M., Maton, N. and Delzenne, N.M., 2005b. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obesity Research 13: 1000-1007.
24. Cani, P.D., Osto, M., Geurts, L. and Everard, A., 2012. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3: 279-288.
25. Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A.M., Lambert, D.M., Muccioli, G.G. and Delzenne, N.M., 2009b. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
26. Castan-Laurell, I., Dray, C., Attane, C., Duparc, T., Knauf, C. and Valet, P., 2011. Apelin, diabetes, and obesity. Endocrine 40: 1-9.
27. Castan-Laurell, I., Dray, C., Knauf, C., Kunduzova, O. and Valet, P., 2012. Apelin, a promising target for type 2 diabetes treatment? Trends in Endocrinology and Metabolism 23: 234-241.
28. Clarke, S.F., Murphy, E.F., Nilaweera, K., Ross, P.R., Shanahan, F., O'Toole, P.W. and Cotter, P.D., 2012. The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes 3: 186-202.
29. Cloetens, L., Broekaert, W.F., Delaedt, Y., Ollevier, F., Courtin, C.M., Delcour, J.A., Rutgeerts, P. and Verbeke, K., 2010. Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. British Journal of Nutrition 103: 703-713.
30. Cluny, N.L., Reimer, R.A. and Sharkey, K.A., 2012. Cannabinoid signalling regulates inflammation and energy balance: the importance of the brain-gut axis. Brain, Behavior, and Immunity 26: 691-698.
31. Collado, M.C., Isolauri, E., Laitinen, K. and Salminen, S., 2008. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. The American Journal of Clinical Nutrition 88: 894-899.
32. Cota, D., Marsicano, G., Tschop, M., Grubler, Y., Flachskamm, C., Schubert, M., Auer, D., Yassouridis, A., Thone-Reineke, C., Ortmann, S., Tomassoni, F., Cervino, C., Nisoli, E., Linthorst, A.C., Pasquali, R., Lutz, B., Stalla, G.K. and Pagotto, U., 2003. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. The Journal of Clinical Investigation 112: 423-431.
33. Dao, T.M., Waget, A., Klopp, P., Serino, M., Vachoux, C., Pechere, L., Drucker, D.J., Champion, S., Barthelemy, S., Barra, Y., Burcelin, R. and Seree, E., 2011. Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control. PLoS ONE 6: e20700.
34. Daviaud, D., Boucher, J., Gesta, S., Dray, C., Guigne, C., Quilliot, D., Ayav, A., Ziegler, O., Carpene, C., Saulnier-Blache, J.S., Valet, P. and Castan-Laurell, I., 2006. TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB Journal 20: 1528-1530.
35. Davis, L.M., Martinez, I., Walter, J., Goin, C. and Hutkins, R.W., 2011. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS ONE 6: e25200.
36. Delzenne, N.M. and Cani, P.D., 2005. A place for dietary fibre in the management of the metabolic syndrome. Current Opinion in Clinical Nutrition and Metabolic Care 8: 636-640.
37. Delzenne, N.M., Neyrinck, A.M., Backhed, F. and Cani, P.D., 2011. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nature Reviews Endocrinology 7: 639-646.
38. Dewulf, E.M., Cani, P.D., Claus, S.P., Fuentes, S., Puylaert, P.G., Neyrinck, A.M., Bindels, L.B., De Vos, W.M., Gibson, G.R., Thissen, J.P. and Delzenne, N.M., 2013. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62: 1112-1121.
39. Dewulf, E.M., Cani, P.D., Neyrinck, A.M., Possemiers, S., Holle, A.V., Muccioli, G.G., Deldicque, L., Bindels, L.B., Pachikian, B.D., Sohet, F.M., Mignolet, E., Francaux, M., Larondelle, Y. and Delzenne, N.M., 2011. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. Journal of Nutritional Biochemistry 22: 712-722.
40. Ding, S., Chi, M.M., Scull, B.P., Rigby, R., Schwerbrock, N.M., Magness, S., Jobin, C. and Lund, P.K., 2010. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 5: e12191.
41. Dray, C., Debard, C., Jager, J., Disse, E., Daviaud, D., Martin, P., Attane, C., Wanecq, E., Guigne, C., Bost, F., Tanti, J.F., Laville, M., Vidal, H., Valet, P. and Castan-Laurell, I., 2010. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. American Journal of Physiology - Endocrinology and Metabolism 298: E1161-E1169.
42. Dray, C., Knauf, C., Daviaud, D., Waget, A., Boucher, J., Buleon, M., Cani, P.D., Attane, C., Guigne, C., Carpene, C., Burcelin, R., Castan-Laurell, I. and Valet, P., 2008. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metabolism 8: 437-445.
43. Dube, P.E. and Brubaker, P.L., 2007. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. American Journal of Physiology - Endocrinology and Metabolism 293: E460-E465.
44. Duparc, T., Colom, A., Cani, P.D., Massaly, N., Rastrelli, S., Drougard, A., Le, G.S., Mouledous, L., Frances, B., Leclercq, I., Llorens-Cortes, C., Pospisilik, J.A., Delzenne, N.M., Valet, P., Castan-Laurell, I. and Knauf, C., 2011a. Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice. Antioxidants and Redox Signaling 15: 1477-1496.
45. Duparc, T., Naslain, D., Colom, A., Muccioli, G.G., Massaly, N., Delzenne, N.M., Valet, P., Cani, P.D. and Knauf, C., 2011b. Jejunum inflammation in obese and diabetic mice impairs enteric glucose detection and modifies nitric oxide release in the hypothalamus. Antioxidants and Redox Signaling 14: 415-423.
46. Eckel, R.H., Grundy, S.M. and Zimmet, P.Z., 2005. The metabolic syndrome. The Lancet 365: 1415-1428.
47. Engeli, S., 2012. Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight. In: Joost, H.-G. (ed.) Appetite control. Handbook of experimental pharmacology Vol. 209. Springer, Berlin, Germany, pp. 357-381.
48. Engeli, S., Bohnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Batkai, S., Pacher, P., Harvey-White, J., Luft, F.C., Sharma, A.M. and Jordan, J., 2005. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54: 2838-2843.
49. Erdem, G., Dogru, T., Tasci, I., Sonmez, A. and Tapan, S., 2008. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Experimental and Clinical Endocrinology and Diabetes 116: 289-292.
50. Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G.M., Neyrinck, A.M., Possemiers, S., Van, H.A., Francois, P., De Vos, W.M., Delzenne, N.M., Schrenzel, J. and Cani, P.D., 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60: 2775-2786.
51. Flint, H.J., 2012. The impact of nutrition on the human microbiome. Nutrition Reviews 70 Suppl. 1: S10-S13.
52. Galic, S., Oakhill, J.S. and Steinberg, G.R., 2010. Adipose tissue as an endocrine organ. Molecular and Cellular Endocrinology 316: 129-139.
53. Gary-Bobo, M., Elachouri, G., Gallas, J.F., Janiak, P., Marini, P., Ravinet-Trillou, C., Chabbert, M., Cruccioli, N., Pfersdorff, C., Roque, C., Arnone, M., Croci, T., Soubrie, P., Oury-Donat, F., Maffrand, J.P., Scatton, B., Lacheretz, F., Le, F.G., Herbert, J.M. and Bensaid, M., 2007. Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology 46: 122-129.
54. Ge, Q., Maury, E., Rycken, L., Gerard, J., Noel, L., Detry, R., Navez, B. and Brichard, S.M., 2013. Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity. International Journal of Obesity 37: 874-880.
55. Geurts, L., Lazarevic, V., Derrien, M., Everard, A., Van Roye, M., Knauf, C., Valet, P., Girard, M., Muccioli, G.G., Francois, P., De Vos, W.M., Delzenne, N.M. and Cani, P.D., 2011. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Frontiers in Microbiology 2: 149.
56. Grootaert, C., Van den Abbeele, P., Marzorati, M., Broekaert, W.F., Courtin, C.M., Delcour, J.A., Verstraete, W. and Van de Wiele, T., 2009. Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem. Fems Microbiology and Ecology 69: 231-242.
57. Gustafson, B., Gogg, S., Hedjazifar, S., Jenndahl, L., Hammarstedt, A. and Smith, U., 2009. Inflammation and impaired adipogenesis in hypertrophic obesity in man. American Journal of Physiology - Endocrinology and Metabolism 297: E999-E1003.
58. Han, S., Wang, G., Qi, X., Englander, E.W. and Greeley Jr., G.H., 2008. Involvement of a Stat3 binding site in inflammation-induced enteric apelin expression. American Journal of Physiology - Gastrointestinal and Liver Physiology 295: G1068-G1078.
59. Hansen, C.H., Krych, L., Nielsen, D.S., Vogensen, F.K., Hansen, L.H., Sorensen, S.J., Buschard, K. and Hansen, A.K., 2012. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55: 2285-2294.
60. Hoareau, L., Buyse, M., Festy, F., Ravanan, P., Gonthier, M.P., Matias, I., Petrosino, S., Tallet, F., d'Hellencourt, C.L., Cesari, M., Di, M.V. and Roche, R., 2009. Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. Obesity 17: 431-438.
61. Hotamisligil, G.S., 2008. Inflammation and endoplasmic reticulum stress in obesity and diabetes. International Journal Obesity 32 Suppl. 7: S52-S54.
62. Johanningsmeier, S.D. and Harris, G.K., 2011. Pomegranate as a functional food and nutraceutical source. Annual Review of Food Science and Technology 2: 181-201.
63. Kalliomaki, M., Collado, M.C., Salminen, S. and Isolauri, E., 2008. Early differences in fecal microbiota composition in children may predict overweight. The American Journal of Clinical Nutrition 87: 534-538.
64. Karlsson, C.L., Onnerfalt, J., Xu, J., Molin, G., Ahrne, S. and Thorngren-Jerneck, K., 2012. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity 20: 2257-2261.
65. Lambert, D.M. and, Muccioli, G.G., 2007. Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players. Current Opinion in Clinical Nutrition and Metabolic Care 10: 735-744.
66. Ley, R.E., 2010. Obesity and the human microbiome. Current Opinion in Gastroenterology 26: 5-11.
67. Liu, J., Batkai, S., Pacher, P., Harvey-White, J., Wagner, J.A., Cravatt, B.F., Gao, B. and Kunos, G., 2003. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. The Journal of Biological Chemistry 278: 45034--45039.
68. Lv, S.Y., Yang, Y.J., Qin, Y.J., Mo, J.R., Wang, N.B., Wang, Y.J. and Chen, Q., 2012. Central apelin-13 inhibits food intake via the CRF receptor in mice. Peptides 33: 132-138.
69. Maccarrone, M., De, P.L., Bari, M., Fezza, F., Salvati, S., Di, M.V. and Finazzi-Agro, A., 2001. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Archives in Biochemistry and Biophysics 393: 321-328.
70. Macfarlane, G.T., Steed, H. and Macfarlane, S., 2008. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. Journal of Applied Microbiology 104: 305-344.
71. Maenhaut, N. and Van, d.V., 2011. Regulation of vascular tone by adipocytes. BMC Medicine 9: 25.
72. Maki, K.C., Gibson, G.R., Dickmann, R.S., Kendall, C.W., Chen, C.Y., Costabile, A., Comelli, E.M., McKay, D.L., Almeida, N.G., Jenkins, D., Zello, G.A. and Blumberg, J.B., 2012. Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal. Nutrition 28: 1115-1121.
73. Matias, I. and Di Marzo,V., 2007. Endocannabinoids and the control of energy balance. Trends in Endocrinology and Metabolism 18: 27-37.
74. Melgar-Lesmes, P., Pauta, M., Reichenbach, V., Casals, G., Ros, J., Bataller, R., Morales-Ruiz, M. and Jimenez, W., 2011. Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes. Gut 60: 1404-1411.
75. Mestdagh, R., Dumas, M.E., Rezzi, S., Kochhar, S., Holmes, E., Claus, S.P. and Nicholson, J.K., 2011. Gut microbiota modulate the metabolism of brown adipose tissue in mice. Journal of Proteome Research 11: 620-630.
76. Moore, W.E. and Moore, L.H., 1995. Intestinal floras of populations that have a high risk of colon cancer. Applied and Environmental Microbiology 61: 3202-3207.
77. Muccioli, G.G., 2010. Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discovery Today 15: 474-483.
78. Muccioli, G.G., Naslain, D., Backhed, F., Reigstad, C.S., Lambert, D.M., Delzenne, N.M. and Cani, P.D., 2010. The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 6: 392.
79. Musso, G., Gambino, R. and Cassader, M., 2010. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Current Opinion in Lipidology 21: 76-83.
80. Neyrinck, A.M. and Delzenne, N.M., 2010. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders. Current Opinion in Clinical Nutrition and Metabolic Care 13: 722-728.
81. Neyrinck, A.M., Possemiers, S., Druart, C., Van de Wiele, T., De, B.F., Cani, P.D., Larondelle, Y. and Delzenne, N.M., 2011. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS ONE 6: e20944.
82. Neyrinck, A.M., Possemiers, S., Verstraete, W., De Backer, F., Cani, P.D. and Delzenne, N.M., 2012a. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. Journal of Nutritional Biochemistry 23: 51-59.
83. Neyrinck, A.M., Van Hee, V.F., Bindels, L.B., De Backer, F., Cani, P.D. and Delzenne, N.M., 2013. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota. British Journal of Nutrition 109: 802-809.
84. Neyrinck, A.M., Van Hee, V.F., Piront, N., De Backer, F., Toussaint, O., Cani, P.D. and Delzenne, N.M., 2012b. Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutrition and Diabetes 2: e28.
85. Ogden, C.L., Yanovski, S.Z., Carroll, M.D. and Flegal, K.M., 2007. The epidemiology of obesity. Gastroenterology 132: 2087-2102.
86. Pagotto, U., Marsicano, G., Cota, D., Lutz, B. and Pasquali, R., 2006. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocrine Reviews 27: 73-100.
87. Parkar, S.G., Stevenson, D.E. and Skinner, M.A., 2008. The potential influence of fruit polyphenols on colonic microflora and human gut health. International Journal of Food Microbiology 124: 295-298.
88. Parnell, J.A. and Reimer, R.A., 2012. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. British Journal of Nutrition 107: 601-613.
89. Pertwee, R.G., 2010. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Current Medicinal Chemistry 17: 1360-1381.
90. Poulain-Godefroy, O., Lecoeur, C., Pattou, F., Fruhbeck, G. and Froguel, P., 2008. Inflammation is associated with a decrease of lipogenic factors in omental fat in women. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 295: R1-R7.
91. Rabot, S., Membrez, M., Bruneau, A., Gerard, P., Harach, T., Moser, M., Raymond, F., Mansourian, R. and Chou, C.J., 2010. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB Journal 24: 4948-4959.
92. Ravinet, T.C., Delgorge, C., Menet, C., Arnone, M. and Soubrie, P., 2004. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. International Journal of Obesity and Related Metabolic Disorders 28: 640-648.
93. Reaux, A., Gallatz, K., Palkovits, M. and Llorens-Cortes, C., 2002. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 113: 653-662.
94. Reaux-Le Goazigo, A., Bodineau, L., De Mota, N., Jeandel, L., Chartrel, N., Knauf, C., Raad, C., Valet, P. and Llorens-Cortes, C., 2011. Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic alpha-MSH release. American Journal of Physiology - Endocrinology and Metabolism 301: E955-E966.
95. Roberfroid, M., 2007. Prebiotics: the concept revisited. Journal of Nutrion 137: 830S-837S.
96. Roberfroid, M., Gibson, G.R., Hoyles, L., McCartney, A.L., Rastall, R., Rowland, I., Wolvers, D., Watzl, B., Szajewska, H., Stahl, B., Guarner, F., Respondek, F., Whelan, K., Coxam, V., Davicco, M.J., Leotoing, L., Wittrant, Y., Delzenne, N.M., Cani, P.D., Neyrinck, A.M. and Meheust, A., 2010. Prebiotic effects: metabolic and health benefits. British Journal of Nutrition 104: S1-S63.
97. Robertson, M.D., 2012. Dietary-resistant starch and glucose metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 15: 362-367.
98. Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J.F., Ardid, D. and Desreumaux, P., 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Medicine 13: 35-37.
99. Ryberg, E., Larsson, N., Sjogren, S., Hjorth, S., Hermansson, N.O., Leonova, J., Elebring, T., Nilsson, K., Drmota, T. and Greasley, P.J., 2007. The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology 152: 1092-1101.
100. Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., Hammer, R.E., Williams, S.C., Crowley, J., Yanagisawa, M. and Gordon, J.I., 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the USA 105: 16767-16772.
101. Santacruz, A., Collado, M.C., Garcia-Valdes, L., Segura, M.T., Martin-Lagos, J.A., Anjos, T., Marti-Romero, M., Lopez, R.M., Florido, J., Campoy, C. and Sanz, Y., 2010. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. British Journal of Nutrition 104: 83-92.
102. Selma, M.V., Espin, J.C. and Tomas-Barberan, F.A., 2009. Interaction between phenolics and gut microbiota: role in human health. Journal of Agricultural and Food Chemistry 57: 6485-6501.
103. Serino, M., Luche, E., Gres, S., Baylac, A., Berge, M., Cenac, C., Waget, A., Klopp, P., Iacovoni, J., Klopp, C., Mariette, J., Bouchez, O., Lluch, J., Ouarne, F., Monsan, P., Valet, P., Roques, C., Amar, J., Bouloumie, A., Theodorou, V. and Burcelin, R., 2012. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61: 543-553.
104. Shen, J., Obin, M.S. and Zhao, L., 2012. The gut microbiota, obesity and insulin resistance. Molecular Aspects of Medicine 34: 39-58.
105. Shen, L., Keenan, M.J., Martin, R.J., Tulley, R.T., Raggio, A.M., McCutcheon, K.L. and Zhou, J., 2009. Dietary resistant starch increases hypothalamic POMC expression in rats. Obesity 17: 40-45.
106. Shoelson, S.E. and Goldfine, A.B., 2009. Getting away from glucose: fanning the flames of obesity-induced inflammation. Nature Medicine 15: 373-374.
107. Slavin, J.L., 2005. Dietary fiber and body weight. Nutrition 21: 411-418.
108. Slavin, J.L., Savarino, V., Paredes-Diaz, A. and Fotopoulos, G., 2009. A review of the role of soluble fiber in health with specific reference to wheat dextrin. Journal of International Medical Research 37: 1-17.
109. Soriguer, F., Garrido-Sanchez, L., Garcia-Serrano, S., Garcia-Almeida, J.M., Garcia-Arnes, J., Tinahones, F.J. and Garcia-Fuentes, E., 2009. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obesity Surgery 19: 1574-1580.
110. Sorli, S.C., Van den Berghe, L., Masri, B., Knibiehler, B. and Audigier, Y., 2006. Therapeutic potential of interfering with apelin signalling. Drug Discovery Today 11: 1100-1106.
111. Tam, J., Vemuri, V.K., Liu, J., Batkai, S., Mukhopadhyay, B., Godlewski, G., Osei-Hyiaman, D., Ohnuma, S., Ambudkar, S.V., Pickel, J., Makriyannis, A. and Kunos, G., 2010. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. Journal of Clinical Investigation 120: 2953-2966.
112. Tilg, H. and Kaser, A., 2011. Gut microbiome, obesity, and metabolic dysfunction. Journal of Clinical Investigation 121: 2126-2132.
113. Tremaroli, V. and Backhed, F., 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249.
114. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
115. Turroni, F., Foroni, E., Pizzetti, P., Giubellini, V., Ribbera, A., Merusi, P., Cagnasso, P., Bizzarri, B., De'Angelis, G.L., Shanahan, F., Van Sinderen, D. and Ventura, M., 2009. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Applied and Environmental Microbiology 75: 1534-1545.
116. Tzounis, X., Vulevic, J., Kuhnle, G.G., George, T., Leonczak, J., Gibson, G.R., Kwik-Uribe, C. and Spencer, J.P., 2008. Flavanol monomer-induced changes to the human faecal microflora. British Journal of Nutrition 99: 782-792.
117. Van Gaal, L.F., Rissanen, A.M., Scheen, A.J., Ziegler, O. and Rossner, S., 2005. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. The Lancet 365: 1389-1397.
118. Vincent, M., Philippe, E., Everard, A., Kassis, N., Rouch, C., Denom, J., Takeda, Y., Uchiyama, S., Delzenne, N.M., Cani, P.D., Migrenne, S. and Magnan, C., 2013. Dietary supplementation with Agaricus blazei Murill extract prevents diet-induced obesity and insulin resistance in rats. Obesity 21: 553-561.
119. Walton, G.E., Van den Heuvel, E.G. Kosters, M.H., Rastall, R.A., Tuohy, K.M. and Gibson, G.R., 2012. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. British Journal of Nutrition 107: 1466-1475.
120. Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., Yu, P., Zhao, C., Li, L., Zhou, A., Wang, J., Moore, J.E., Millar, B.C. and Xu, J., 2010. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Current Microbiology 61: 69-78.
121. Yue, P., Jin, H., Aillaud, M., Deng, A.C., Azuma, J., Asagami, T., Kundu, R.K., Reaven, G.M., Quertermous, T. and Tsao, P.S., 2010. Apelin is necessary for the maintenance of insulin sensitivity. American Journal of Physiology - Endocrinology and Metabolism 298: E59-E67.
122. Zhou, J., Martin, R.J., Tulley, R.T., Raggio, A.M., McCutcheon, K.L., Shen, L., Danna, S.C., Tripathy, S., Hegsted, M. and Keenan, M.J., 2008. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. American Journal of Physiology - Endocrinology and Metabolism 295: E1160-E1166.